Global Vascular Closure Devices Market to Surpass US$ 1440.3 Million Threshold by 2025

VASCULAR CLOSURE DEVICE
MARKET
INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND
OPPORTUNITY ANALYSIS, 2017–2025
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION
Vascular Closure Devices Market: Overview
The Global Vascular Closure Devices Market by Product Type (Passive Vascular Closure
Devices, Active Vascular Closure Devices, and External Hemostatic Devices), By Access
(Femoral and Radial), by Hole Size (Small Hole and Large Hole), by End User (Hospitals,
Ambulatory Surgical Centers, and Others) and by Region (North America, Latin America,
Europe, Asia Pacific, the Middle East, and Africa) was valued at US$ 848.2 Mn in 2016 and is
projected to exhibit a CAGR of 6.1% over the forecast period (2017 – 2025), as highlighted in
a new report published by Coherent Market Insights. Multiple approvals and launch of novel
innovative devices is expected to support the growth of global vascular closure devices
market.
Request Sample: https://www.coherentmarketinsights.com/insight/request-sample/1330
In 2016, Essential Medical, Inc., received CE Mark approval for product MANTA, which is a
bore vascular closure device. In 2016, Vasorum Ltd. received U.S. Food and Drug
Administration (U.S. FDA) approval for vascular closure device Celt ACD. In 2014, Cardinal
Health received U.S. FDA approval for MynxGrip vascular closure device used for closure of
femoral veins. The lucrative vascular closure devices market has witnessed multiple product
launches in recent years. Thereby, increasing number of products in the market is expected
to boost growth of the global vascular closure devices market.
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION
Market players are focused on acquiring competitors or particular business segment (i.e.
vascular closure device segment) from the competitors in order to increase product portfolio
and to strengthen their position in vascular closure devices market. For instance, in January
2017, Terumo Corporation acquired some of vascular closure products owned by Abbott and
St. Jude Medical, Inc. for a total amount of US$ 1.12 billion. The acquired product include St
Jude Medical’s Angio-Seal and FemoSeal vascular closure product lines and Abbott’s Vado
Steerable Sheath. An estimate total revenue generated by these products was US$ 268 Mn
in 2016. Furthermore, Abbott Laboratories acquired St. Jude Medical, Inc. in January 2017 in
order to strengthen its position in cardiovascular devices including vascular closure devices
market. In 2014, Cardinal Health Inc. acquired AccessClosure Inc. for US$ 320 Mn in cash in
order to expand vascular closure device product portfolio. In 2017, Teleflex Incorporated
have acquired Vascular Solutions, Inc. This strategic acquisition have widen the vascular
closure device product portfolio of Teleflex Incorporated.
Browse 34 Market Data Tables and 28 Figures spread through 195 Pages and in-depth TOC
on Vascular Closure Device Market, by Product Type (Passive Vascular Closure Devices,
Active Vascular Closure Devices, and External Hemostatic Devices), By Access (Femoral, and
Radial), By Hole Size (Small Hole, and Large Hole) By End User (Hospital, Ambulatory Surgical
Centers, and Others) and Region (North America, Latin America, Europe, Asia Pacific, the
Middle East, and Africa) - Global Forecast to 2025
Request Customization: https://www.coherentmarketinsights.com/insight/requestcustomization/1330
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION
Key Takeaways of the Vascular Closure Devices Market:
• The global vascular closure devices market is expected to exhibit a CAGR of 6.1% over the
forecast period (2017 – 2025), owing to frequent approval by regulatory bodies to
innovative products in key regions
• North America is expected to continue dominance during the forecast period (2017 2025), owing to launches of novel vascular closure devices in the regions by key players.
• The market has witnessed multiple product launches in recent years and the trend is
expected to continue during the forecast period as leading players are continuously
involved in R & D to develop products with efficient technology
• Mergers/Acquisitions (M&A) and Collaborations has been the major focus of leading
companies in this field. Increasing competition in this market may lead to further increase
in these activities (M&A and Collaborations).
• Major players operating in the global vascular closure devices market include Abbott
Laboratories, Medtronic Plc, Transluminal Technologies LLC, Cardinal Health, Inc., Cardiva
Medical, Inc., Terumo Corporation, Essential Medical, Inc., Vascular Closure Systems, Inc.,
Vivasure Medical Ltd., Vasorum Ltd., and Morris Innovative Inc
Request Discount: https://www.coherentmarketinsights.com/insight/requestdiscount/1330
© Coherent market Insights. All Rights Reserved
ABOUT COHERENT MARKET INSIGHTS
ABOUT US
Coherent Market Insights is a global market intelligence and consulting organization focused on
assisting its plethora of clients achieve transformational growth by helping them make critical business
decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our
client base includes players from across all business verticals in over 150 countries worldwide. We are
uniquely positioned to help businesses around the globe deliver practical and lasting results through
various recommendations about operational improvements, technologies, emerging market trends and
new working methods. We offer both customized and syndicated market research reports that help our
clients create visionary growth plans to provide traction to their business. We meticulously study
emerging trends across various industries at both the global and regional levels to identify new
opportunities for our clientele.
SERVICES
INDUSTRY ANALYSIS
CUSTOMIZED
RESEARCH
SYNDICATED RESEARCH
MARKET INTELLIGENCE
SERVICES
CONSULT STUDIES
COUNTRY SPECIFIC
STUDIES
© Coherent market Insights. All Rights Reserved
ABOUT CMI
SECTOR COVERAGE
BIOTECHNOLOGY
CLINICAL DIAGNOSTIC
HEALTHCARE IT
MEDICAL DEVICES
MEDICAL IMAGING
PHARMACEUTICAL
OUR CLIENTS
 Global Leading Equipment and System Manufacturers  Marketing Consultancies and the Advertising Industry
 Component Providers and System Integrators
 Private and Government organization
 Distributors, Retailors and Value Added Resellers
 Outsourcing Companies
 Healthcare IT Solutions Developers
 Universities and Business Schools.
© Coherent market Insights. All Rights Reserved
KEY STATS
RESEARCH SOLUTIONS
100+
FEASIBILITY
STUDIES
Insights Published
Per Year
GLOBAL
REPORTS
150+
Consulting Projects
Till Date
COUNTRY
ANALYSIS
CONSULT
PROJECTS
125+
Clients Worldwide
Per Year
110+
SURVEY
RESEARCH
EXCEL
FORECAST
DATABASE
CUSTOMIZED
SOLUTIONS
COMPETITIVE
ASSESSMENT
TECHNOLOGY
SNIPPETS
Analysts and Contract
Consultants
Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals,
including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in
order to result in the best possible market research reports across various industries worldwide. Based on our unmatched
expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better
outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure
sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of
opportunities posed therein.
© Coherent market Insights. All Rights Reserved
THANK YOU
To know more about us, visit our website:
www.coherentmarketinsights.com
For sales queries or new topics email us on:
[email protected]
For other queries contact:
Mr. Shah
(Manager - Business Development)
Coherent Market Insights
[email protected]
+1-206-701-6702
© Coherent market Insights. All Rights Reserved

Global Vascular Closure Devices market to surpass US$ 1440.3 million threshold by 2025 worldwide with the frequent approval of novel vascular closure devices by regulatory bodies